Department of Pathology, IIB-Sant Pau, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
Biobanco IIB Sant Pau, IIB-Sant Pau, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
Hum Pathol. 2014 May;45(5):942-51. doi: 10.1016/j.humpath.2013.12.007. Epub 2014 Jan 8.
Micro-RNA (miRNA) signatures influence the prognosis of cancer, but little is known about their role in myometrial invasion in endometrioid endometrial adenocarcinoma (EEC). We studied miRNA expression signatures in noninvasive and invasive EEC focusing on the alteration of miR-27 and its main target, FOXO1 as well as their relationship with the clinicopathological parameters and other genetic alterations such as PIK3CA mutations. In 25 tumors and 5 normal endometria, unsupervised hierarchical clustering analysis showed that normal endometria and noninvasive EEC were grouped together and separately from invasive and advanced stage tumors. Of the 20 miRNAs differentially expressed in noninvasive (stage IA) and myoinvasive adenocarcinomas (stage IB and IC), miR27 was overexpressed in invasive adenocarcinomas, and its expression increased linearly according to stage. Results were validated by quantitative real-time reverse transcription polymerase chain reaction in an independent series of 44 EEC. By in situ hybridization, miR-27 expression was limited to the stroma. Using quantitative real-time reverse transcription polymerase chain reaction, the expression of proapoptotic transcription factor FOXO1 was down-regulated in invasive compared with noninvasive tumors. Furthermore, we found that the expression of active caspase 3 was higher in noninvasive than invasive EEC. When stratified by PIK3CA mutations, all invasive tumors down-regulated FOXO1, but only nonmutated adenocarcinomas showed miR-27 overexpression. In conclusion, we propose that the miR27-FOXO1 tandem inhibits apoptosis and represents an alternative pathway for tumor cell survival in PIK3CA-nonmutated EEC.
微 RNA(miRNA)特征影响癌症的预后,但它们在子宫内膜样子宫内膜腺癌(EEC)中的肌层浸润中的作用知之甚少。我们研究了非浸润性和浸润性 EEC 中的 miRNA 表达特征,重点研究了 miR-27 及其主要靶标 FOXO1 的变化,以及它们与临床病理参数和其他遗传改变(如 PIK3CA 突变)的关系。在 25 个肿瘤和 5 个正常子宫内膜中,无监督层次聚类分析显示正常子宫内膜和非浸润性 EEC 与浸润性和晚期肿瘤分组在一起。在非浸润性(IA 期)和肌浸润性腺癌(IB 和 IC 期)中差异表达的 20 个 miRNA 中,miR-27 在浸润性腺癌中过表达,并且其表达根据分期线性增加。在 44 个 EEC 的独立系列中,通过定量实时逆转录聚合酶链反应验证了结果。通过原位杂交,miR-27 表达仅限于基质。通过定量实时逆转录聚合酶链反应,与非浸润性肿瘤相比,促凋亡转录因子 FOXO1 在浸润性肿瘤中的表达下调。此外,我们发现非浸润性 EEC 中的活性 caspase 3 表达高于浸润性 EEC。当按 PIK3CA 突变分层时,所有浸润性肿瘤下调 FOXO1,但只有非突变性腺癌显示 miR-27 过表达。总之,我们提出 miR27-FOXO1 串联抑制细胞凋亡,代表 PIK3CA 非突变型 EEC 中肿瘤细胞存活的替代途径。